Author: BusinessWire

A new multi-year drug discovery agreement will focus on CNS drug discovery
KYIV, Ukraine–(BUSINESS WIRE)–Enamine Ltd. a provider of drug discovery services empowered with the world’s largest collections of building blocks, fragments and screening co…

Non-invasive genetic test enables physicians to assess an individual’s risk of cognitive decline due to Alzheimer’s from a simple saliva sample provided from home

Test can guide lifestyle interventions to potentially slow disease progression
OXFORD &…

Non-invasive genetic test enables physicians to assess an individual’s risk of cognitive decline due to Alzheimer’s from a simple saliva sample provided from home

Test can guide lifestyle interventions to potentially slow disease progression
OXFORD &…

-Alliance enables support for bioreactor systems and related products in the United States-
TOKYO & SOUTHBOROUGH, Mass.–(BUSINESS WIRE)–#Yokogawa–Yokogawa Electric Corporation (TOKYO:6841) (Yokogawa) and Integrated Commissioning and Qualification C…

-Alliance enables support for bioreactor systems and related products in the United States-
TOKYO & SOUTHBOROUGH, Mass.–(BUSINESS WIRE)–#Yokogawa–Yokogawa Electric Corporation (TOKYO:6841) (Yokogawa) and Integrated Commissioning and Qualification C…

-Alliance enables support for bioreactor systems and related products in the United States-
TOKYO & SOUTHBOROUGH, Mass.–(BUSINESS WIRE)–#Yokogawa–Yokogawa Electric Corporation (TOKYO:6841) (Yokogawa) and Integrated Commissioning and Qualification C…

-Alliance enables support for bioreactor systems and related products in the United States-
TOKYO & SOUTHBOROUGH, Mass.–(BUSINESS WIRE)–#Yokogawa–Yokogawa Electric Corporation (TOKYO:6841) (Yokogawa) and Integrated Commissioning and Qualification C…

-Alliance enables support for bioreactor systems and related products in the United States-
TOKYO & SOUTHBOROUGH, Mass.–(BUSINESS WIRE)–#Yokogawa–Yokogawa Electric Corporation (TOKYO:6841) (Yokogawa) and Integrated Commissioning and Qualification C…

Phase 2 trial to evaluate valemetostat in patients with five disease subtypes along with a planned robust translational research program

TOKYO & BASKING RIDGE, N.J. & MUNICH & LYON, France–(BUSINESS WIRE)–Daiichi Sankyo Company, Limited (hereafter…

Takeda is making two COVID-19 vaccines available in Japan, by manufacturing Novavax’ recombinant vaccine candidate and by distributing Moderna’s mRNA vaccine candidate, with the support of the Japanese Government

Phase 1/2 immunogenicity and safety…